Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
Journal: Inflammation
Published: June 18, 2020
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers.
Journal: Clinical pharmacology in drug development
Published: January 15, 2020
The Potential Role of the J-Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium.
Journal: Journal of clinical pharmacology
Published: February 26, 2019
A Time of Optimism: Targeted Immunotherapeutics as the Long-Awaited Armamentaria Against the Scourge of Human Diseases.
Journal: Therapeutic innovation & regulatory science
Published: February 20, 2019
A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers.
Journal: Journal of clinical pharmacology
Published: June 07, 2018
Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.
Journal: Clinical immunology (Orlando, Fla.)
Published: February 02, 2018
The novel combination of theophylline and bambuterol as a potential treatment of hypoxemia in humans.
Journal: Canadian journal of physiology and pharmacology
Published: May 04, 2017
Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia.
Journal: Clinical pharmacology and therapeutics
Published: March 24, 2017
Intra-Target Microdosing - A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans.
Journal: Clinical and translational science
Published: March 13, 2017
Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.
Journal: Clinical and translational science
Published: January 04, 2017
The Burden of the "False-Negatives" in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures.
Journal: Clinical and translational science
Published: October 20, 2016
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects.
Journal: Journal of clinical pharmacology
Published: September 26, 2016
Last Updated: 09/26/2026